Barbara Duncan
2012
In 2012, Barbara Duncan earned a total compensation of $1.2M as Chief Financial Officer and Treasurer at Intercept Pharmaceuticals, a 143% increase compared to previous year.
Compensation breakdown
| Bonus | $46,016 |
|---|---|
| Non-Equity Incentive Plan | $105,984 |
| Option Awards | $246,668 |
| Salary | $323,000 |
| Stock Awards | $446,533 |
| Other | $8,816 |
| Total | $1,177,017 |
Duncan received $446.5K in stock awards, accounting for 38% of the total pay in 2012.
Duncan also received $46K in bonus, $106K in non-equity incentive plan, $246.7K in option awards, $323K in salary and $8.8K in other compensation.
Rankings
In 2012, Barbara Duncan's compensation ranked 5,497th out of 11,487 executives tracked by ExecPay. In other words, Duncan earned more than 52.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,497 out of 11,487 | 52nd |
Division Manufacturing | 1,937 out of 4,253 | 55th |
Major group Chemicals And Allied Products | 468 out of 1,198 | 61st |
Industry group Drugs | 310 out of 920 | 66th |
Industry Pharmaceutical Preparations | 241 out of 700 | 66th |
Source: SEC filing on April 12, 2013.
Duncan's colleagues
We found two more compensation records of executives who worked with Barbara Duncan at Intercept Pharmaceuticals in 2012.